Medical Advocates
HIV Infection/Disease
  Serum Lipids/Disorders
General Reports
 Special Populations
 Serum Lipids and ARV Therapy
 Serum Lipid Disorders
 Dyslipidemia
 Hyperlipidemia




 
HIV Metabolic Disorders Main Page   Main New/Newsworthy Home Page  
Last Update: July 08, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
       

          Journal Papers, Abstracts, and Commentaries

 
Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan.
Oka F, Naito T, Oike M,  et al
J Infect Chemother. 2011 Jul 7.
Abstract

Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not
inflammatory markers in ACTG 5087.
Fichtenbaum CJ, Yeh TM, Evans SR, Aberg JA.
J Clin Lipidol. 2010 Jul 1;4(4):279-287
 Abstract

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected
Patients Under Antiretroviral Treatment.
Giralt M, Díaz-Delfín J, Gallego-Escuredo JM, et al
Curr Pharm Des. 2010 Aug 5.
 Abstract

Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory
markers in HIV-infected patients treated with antiretroviral therapy: A randomized, double-blind,
placebo-controlled study.
Thusgaard M, Christensen JH, Mørn B,  et al
Scand J Infect Dis. 2009 Aug 14:1-7
 Abstract

New Options in the Treatment of Lipid Disorders in HIV-Infected Patients.
da Silva EF, Bárbaro G.
 Open AIDS J. 2009 Jul 16;3:31-7.
 Abstract

Effectiveness of lipid-lowering therapy in HIV patients.
Martínez E, Leyes P, Ros E.
 Curr Opin HIV AIDS. 2008 May;3(3):240-6.
 Abstract

Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection.
Silverberg MJ, Leyden W, Hurley L, et al 
Ann Intern Med. 2009 Mar 3;150(5):301-13
 Abstract
 
Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy.
Aberg JA
Endocrinol Metab Clin North Am. 2009 Mar;38(1):207-222
 Abstract

The Association Between the Receipt of Lipid Lowering Therapy and HIV Status Among Veterans
Who Met NCEP/ATP III Criteria for the Receipt of Lipid Lowering Medication.
Freiberg MS, Leaf DA, Goulet JL, et al 
J Gen Intern Med. 2009 Jan 6.
Abstract
 
A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients
Initiating Combination Antiretroviral Therapy.
 Walmsley S, Cheung AM, Fantus G, et al
 HIV Clin Trials. 2008 Sep-Oct;9(5):314-23.
 Abstract
 
LIPID abnormalities in patients infected with human immunodeficiency virus.
Mikhail NE.
Endocr Pract. 2008 May-Jun;14(4):492-500.
 Abstract
 
High-Density Lipoprotein Cholesterol in HIV-Infected Patients: Evidence for an Association
with HIV-1 Viral Load, Antiretroviral Therapy Status, and Regimen Composition.
Bernal E, Masiá M, Padilla S, Gutiérrez F.
AIDS Patient Care STDS. 2008 May 15
 Abstract
 
HIV and HIV treatment: effects on fats, glucose and lipids.
Gkrania-Klotsas E, Klotsas AE.
Br Med Bull. 2007 Nov 2
 Abstract
 
Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with
metabolic abnormalities in the HAART era.
Joy T, Keogh HM, Hadigan C, Lee H, et al
AIDS. 2007 Jul 31;21(12):1591-1600
 Abstract
 
Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease
inhibitor containing HAART.
 Tomazic J, Karner P, Vidmar L, Maticic M,  et al; 
Pharmacol Ther. 2005 Oct 15;22(8):685-700.
 Abstract
 
FULL-TEXT PDF ARTICLE
 Changes in lipids over twelve months after initiating protease inhibitor therapy
among persons treated for HIV/AIDS.
 Levy AR, McCandless L, Harrigan PR, et al   |
Lipids Health Dis. 2005 Feb 10;4(1):4
 PDF Paper
 
Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-
infected individuals.
Carpentier A, Patterson BW, Uffelman KD, Salit I, Lewis GF.
Atherosclerosis. 2005 Jan;178(1):165-72.
 Abstract

Antiphospholipid Antibody Syndrome Manifesting as a Deep Venous Thrombosis
and Pulmonary Embolism in a Patient with HIV.
Shahnaz S, Parikh G, Opran A.
Am J Med Sci. 2004 Apr;327(4):231-232.
 Abstract
 
Impact of urbanisation on serum lipid profiles--the THUSA survey.
Oosthuizen W, Vorster HH, Kruger A.
S Afr Med J. 2002 Sep;92(9):723-8.
Abstract
 
  Dietary intake, serum lipids, insulin resistance and body composition in the era of
highly active antiretroviral therapy 'Diet FRS Study'.
Batterham MJ, Garsia R, Greenop PA.
AIDS. 2000 Aug 18;14(12):1839-43.
Abstract

          Conference Reports, Abstracts, and Posters

  Effect of a Low Dose of Salmon Oil on Triglycerides and Lipid Parameters in HIV
Patients Receiving a HAART Regimen and Having Elevated Serum Triglyceride
Levels and Total Cholesterol / High Density Lipoprotein Ratio
J-G Baril, C Kovacs, S Trottier, et al 
(13 CROI)
Abstract

Special Populations
       
Children

          Journal Papers, Abstracts, and Commentaries

  Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in
protease inhibitor-treated and naive HIV-infected children.
Bitnun A, Sochett E, Babyn P,
AIDS. 2003 Jun 13;17(9):1319-27.
Abstract

Women

          Journal Papers, Abstracts, and Commentaries

  Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women
on highly active antiretroviral therapy: a 3.5-year study.
Mahajan AP, Tashima KT, Bausserman LL
J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):332-5.
 Abstract

Men

          Journal Papers, Abstracts, and Commentaries

 
Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in t
riglyceride-rich lipoproteins.
Rimland D, Guest JL, Hernandez I, et al
 HIV Med. 2005 Sep;6(5):326-33.
Abstract

Impact of HIV Infection and HAART on Serum Lipids in Men.
Riddler SA, Smit E, Cole SR, et al
 JAMA. 2003 Jun 11;289(22):2978-82.
Abstract

Serum Lipids and ARV Therapy
       

          Journal Papers, Abstracts, and Commentaries

 
Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy:
Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?
Fontas E, Van Leth F, Sabin CA, et al
J Infect Dis. 2004 Mar 15;189(6):1056-74.
Abstract

Serum lipid levels associated with increased risk for cardiovascular disease is
associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
Koppel K, Bratt G, Eriksson M, Sandstrom E.
Int J STD AIDS. 2000 Jul;11(7):451-5.
Abstract

           Conference Reports, Abstracts, and Posters

 
Association of Lipid Changes in HAART-treated Individuals with Apolipoprotein Genotypes
ED Gometz, D Grimm, M King, et al 
(13 CROI)
 Abstract
 
Long-term changes in lipids and glucose/insulin levels among HIV-infected antiretroviral naïve
persons randomized to PI vs. NNRTI vs. PI + NNRTI-based antiretroviral regimens: results of
the CPCRA 061 metabolic study
 Shlay J., Bartsch G., Peng G., et al 
(XVI International AIDS Conference)
 Abstract

POSTER
The Effects of Enfuvirtide Therapy on Body Composition and Serum Lipids through
48 Weeks in the TORO Trials
DA Cooper, P Reiss, K Henry, et al
(11 CROI)
 PDF Poster      Abstract

Serum Lipid Disorders
       
Adipose Tissue Disorders
Dyslipidemia
Hyperlipidemia
Lipodystrophy
Lipodystrophy Syndrome

HIV Metabolic Disorders Main Page   Main New/Newsworthy Home Page  

HIV Serum Lipids/Disorders